Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cystatin C and Beta 2 Microglobulin as Biochemical Markers for Early Detection of Renal Impairment in Children With Beta Thalassemia

NCT03881917 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT03881917
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03881917 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cystatin C and Beta 2 Microglobulin as Biochemical Markers for Early Detection of Renal Impairment in Children With Beta Thalassemia
Lead sponsor
Assiut University
Phase
Observational
Overall status
Unknown status
Start date
November 1, 2019
Completion date
March 1, 2021
Enrollment
150 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

blood disease